跳至主要内容
临床试验/IRCT2016120531252N1
IRCT2016120531252N1已完成2 期

The effect of combination therapy with Atorvastatin and Aspirin on the severity of fibrosis and liver function in compensated cryptogenic cirrhosis

Office of Research & Technology, Qom University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • patients with compensated cryptogenic cirrhosis; living in Qom; Age of 18 to 75 years; patient without another type of cirrhosis; who have not been treated with statins; patients with serum LDL>70; Patients with PLT>50000
  • Exclusion criteria: Increased liver enzymes more than three times, three months after treatment; Lack of cooperation in the proper use of drugs; Statin-induced myopathy; use of Fibrates, Erythromycin, and other drugs that suppressed metabolism of p450 liver enzyme

排除标准

  • 未提供

研究者

发起方
Office of Research & Technology, Qom University of Medical Sciences

相似试验